CELG

Subscriber Request Series: Celgene Corp (NAS:CELG) and Bristol Myers (NYS:BMY)

2019-07-11

Research Articles

FAST Graphs Analyze Out Loud Celgene Corp $CELG: Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include REVLIMID, POMALYST, IMNOVID, OTEZLA, ABRAXANE, and VIDAZA. The company was founded by David Stirling and […]

Celgene: Growth At A Reasonable Price Even On Revised Guidance

2017-10-27

Research Articles

Introduction This article is an update to my original article on Celgene (CELG) published on June 22, 2017.  Celgene reported their financial results yesterday October 26, 2017, and although the quarter was good, lowered guidance crushed the stock price.  In my opinion, some of the sag in price was justified, but for the most part […]

When is the PEG Ratio Superior to the P/E Ratio? Part 2

2016-11-03

Research Articles

Introduction Financial metrics such as P/E ratios, price to cash flow ratios, PEG ratios, price to sales ratios, price to book value, and many others, should be thought of as tools in the investor’s toolbox.  They can all be useful when appropriately utilized towards putting together a successful stock portfolio.  However, just as you wouldn’t […]

5 Attractive Biotechnology Stocks for Healthy Long-term Returns

2016-06-10

Research Articles

Introduction I am a fervent believer that investors are best served by investing towards a specific investment objective that suits their own unique goals, objectives and risk tolerance.  In other words, investing is not always trying to get the highest possible total returns.  If that were true, no one would have ever invested in bonds, […]

Celgene: A Primer on Growth Stock Value Investing (GARP): Part 2

2015-11-13

Research Articles

Introduction This article is the second in a two-part series on applying the principles of value investing.  In part 1 found here my primary focus was on the benefits of investing in fundamentally strong dividend growth stocks when they are out of favor, and therefore, undervalued as a result.  In this part 2, I will […]

Choosing Common Stocks That Make Sense for Your Retirement Portfolio: Part 2

2015-09-17

Research Articles

Choosing Common Stocks That Make Sense for Your Retirement Portfolio: Part 2 Introduction Choosing the most appropriate stocks for the common stock portion of your retirement portfolio is vitally important.  In part 1 of this series found here I presented the 6 broad categories of stocks (businesses) that renowned mutual fund manager Peter Lynch presented […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.